Different Molecular Phenotypes of Progression in BRAF- and RAS-Like Papillary Thyroid Carcinoma
Endocrinology and Metabolism · 2023
DOI: 10.3803/enm.2023.1702 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology and Metabolism, 2023. Verfasst von Jinsun Lim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, CHA University School of Medicine, Seongnam, Korea. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Carcinoma, Papillary. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT.
Abstract (Originalsprache)
Background
Papillary thyroid carcinoma (PTC) can be classified into two distinct molecular subtypes, BRAF-like (BL) and RASlike (RL). However, the molecular characteristics of each subtype according to clinicopathological factors have not yet been determined. We aimed to investigate the gene signatures and tumor microenvironment according to clinicopathological factors, and to identify the mechanism of progression in BL-PTCs and RL-PTCs.
Methods
We analyzed RNA sequencing data and corresponding clinicopathological information of 503 patients with PTC from The Cancer Genome Atlas database. We performed differentially expressed gene (DEG), Gene Ontology, and molecular pathway enrichment analyses according to clinicopathological factors in each molecular subtype. EcoTyper and CIBERSORTx were used to deconvolve the tumor cell types and their surrounding microenvironment.
Results
Even for the same clinicopathological factors, overlapping DEGs between the two molecular subtypes were uncommon, indicating that BL-PTCs and RL-PTCs have different progression mechanisms. Genes related to the extracellular matrix were commonly upregulated in BL-PTCs with aggressive clinicopathological factors, such as old age (≥55 years), presence of extrathyroidal extension, lymph node metastasis, advanced tumor-node-metastasis (TNM) stage, and high metastasis-age-completeness of resection- invasion-size (MACIS) scores (≥6). Furthermore, in the deconvolution analysis of tumor microenvironment, cancer-associated fibroblasts were significantly enriched. In contrast, in RL-PTCs, downregulation of immune response and immunoglobulin-related genes was significantly associated with aggressive characteristics, even after adjusting for thyroiditis status.
Conclusion
The molecular phenotypes of cancer progression differed between BL-PTC and RL-PTC. In particular, extracellular matrix and cancer-associated fibroblasts, which constitute the tumor microenvironment, would play an important role in the progression of BL-PTC that accounts for the majority of advanced PTCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, CHA University School of Medicine, Seongnam, Korea.
- Department of Biomedical Science, Graduate School, CHA University, Seongnam, Korea.
- Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea.
- Department of Internal Medicine, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea.
Förderung
- National Research Foundation of Korea
- Ministry of Science and ICT
Zitieren
APA
Lim, J., Lee, H. S., Park, J., Kim, K. S., Kim, S. K., Cho, Y. W., & Song, Y. S. (2023). Different Molecular Phenotypes of Progression in BRAF- and RAS-Like Papillary Thyroid Carcinoma. Endocrinology and Metabolism. https://doi.org/10.3803/enm.2023.1702
Vancouver
Lim J, Lee HS, Park J, Kim KS, Kim SK, Cho YW, et al. Different Molecular Phenotypes of Progression in BRAF- and RAS-Like Papillary Thyroid Carcinoma. Endocrinology and Metabolism. 2023. doi:10.3803/enm.2023.1702
BibTeX
@article{Lim2023,
author = {Lim, Jinsun and Lee, Han Sai and Park, Jiyun and Kim, Kyung-Soo and Kim, Soo-Kyung and Cho, Yong-Wook and Song, Young Shin},
title = {Different Molecular Phenotypes of Progression in BRAF- and RAS-Like Papillary Thyroid Carcinoma},
journal = {Endocrinology and Metabolism},
year = {2023},
doi = {10.3803/enm.2023.1702}
}
EUVIMED